BIONET Corp. (TPEX:1784)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Stem Cells and Genetic Testing Products	1.21B	1.30B	1.23B	1.07B	1.00B
Write-Off Due to Consolidation	-222.49M	-325.44M	-218.02M	-184.30M	-191.27M
Other Departments	246.30M	242.85M	113.37M	97.21M	111.54M
Total	1.24B	1.22B	1.13B	980.38M	921.42M

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Taiwan	1.21B	1.20B	1.11B	960.31M	902.45M
Other	23.05M	21.45M	17.47M	20.07M	18.97M
Total	1.24B	1.22B	1.13B	980.38M	921.42M

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error